GAVRETO
GAVRETO
Discontinued
DIN Number
02517590
Drug Class
Human
Market Date
Nov 12, 2021
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02517590
AIG Number0163030001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX23 PRALSETINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PRALSETINIBActive
Strength: 100 MG
Monograph: PRALSETINIB